RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY

Recruiting

• Conditions: the Records of Esophageal Cancer
• Interventions: Diagnostic Test: Since the data were collected retrospectively, there were no interventions

• Registration Number: NCT05570487
• Lead Sponsor: Yongtao Han

Brief Summary

To clarify the effect of the number of lymph node dissection and the number of stations on survival

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-10
• Study Start: 2022-10-01
• Study First Submitted: 2022-10-04
• Study First Submitted QC: 2022-10-04
• Study First Posted: 2022-10-06
• Last Update Submitted: 2022-10-24
• Last Update Posted: 2022-10-25
• Primary Completion: 2022-12-01
• Study Completion: 2023-10-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1600

Inclusion Criteria

1. Men and women aged 18-85;
2. Histologically confirmed primary thoracic esophageal squamous cell carcinoma,
3. Staging PT1-4A, N0-3, M0 AJCC eighth edition;
4. Excluding lymph node dissection < 15,(meeting the guideline criteria)

Exclusion Criteria

1. Patients with a history of previous thoracic and abdominal surgery that may affect lymphatic reflux
2. Patients with distant metastasis confirmed by imaging;
3. Patients with obvious surgical contraindications.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
N0A Group	Since the data were collected retrospectively, there were no interventions	patients with negative lymph nodes and resected lymph nodes less than 15
N0B Group	Since the data were collected retrospectively, there were no interventions	patients with negative lymph nodes and resected lymph nodes no less than 15
N+A Group	Since the data were collected retrospectively, there were no interventions	patients with positive lymph nodes and resected lymph nodes less than 15
N+B Group	Since the data were collected retrospectively, there were no interventions	patients with positive lymph nodes and resected lymph nodes no less than 15

Primary Outcome Measures

Name	Time	Method
The number of lymph nodes	2010.1.1-2017.12.30	Surgical data were retrospectively collected

Trial Locations

Locations (1)

Sichuan Cancer Hospital; 🇨🇳 Chendu, Sichuan, China